Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Albelda

Showing results (21-30 of 197) with videos related to

Pageof 20
Sort By:
Annual Review of Medicine|November 19, 2016
CAR T Cell Therapy for Solid TumorsKheng Newick, Shaun O'Brien, Edmund Moon, et al.
The Lancet. Oncology|March 7, 2018
Novel therapies for malignant pleural mesotheliomaArnaud Scherpereel, Frederic Wallyn, Steven M Albelda, et al.
American Journal of Respiratory Cell and Molecular Biology|February 18, 2010
Gene therapy for mesothelioma and lung cancerAnil Vachani, Edmund Moon, Elliot Wakeam, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 9, 2008
Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopesCarmen Garnacho, Steven M Albelda, Vladimir R Muzykantov, et al.
Blood|December 7, 2002
PECAM-1-dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localizationChristopher D O'Brien, Poay Lim, Jing Sun, et al.
International Journal of Molecular Sciences|March 4, 2016
Asbestos Induces Oxidative Stress and Activation of Nrf2 Signaling in Murine Macrophages: Chemopreventive Role of the Synthetic Lignan Secoisolariciresinol Diglucoside (LGM2605)Ralph A Pietrofesa, Anastasia Velalopoulou, Steven M Albelda, et al.
Biochemical and Biophysical Research Communications|July 14, 2004
Role of lateral cell-cell border location and extracellular/transmembrane domains in PECAM/CD31 mechanosensationDavid A Kaufman, Steven M Albelda, Jing Sun, et al.
Cancers|September 2, 2017
Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)Astero Klampatsa, Andrew R Haas, Edmund K Moon, et al.
Frontiers in Cell and Developmental Biology|November 2, 2016
Diacylglycerol Kinases (DGKs): Novel Targets for Improving T Cell Activity in CancerMatthew J Riese, Edmund K Moon, Bryon D Johnson, et al.
Cancer Biology & Therapy|June 22, 2007
Gemcitabine has significant immunomodulatory activity in murine tumor models independent of its cytotoxic effectsEiji Suzuki, Jing Sun, Veena Kapoor, et al.
Pageof 20

Showing results (21-30 of 197) with videos related to

Sort By:
Pageof 20
Annual Review of Medicine|November 19, 2016
CAR T Cell Therapy for Solid TumorsKheng Newick, Shaun O'Brien, Edmund Moon, et al.
The Lancet. Oncology|March 7, 2018
Novel therapies for malignant pleural mesotheliomaArnaud Scherpereel, Frederic Wallyn, Steven M Albelda, et al.
American Journal of Respiratory Cell and Molecular Biology|February 18, 2010
Gene therapy for mesothelioma and lung cancerAnil Vachani, Edmund Moon, Elliot Wakeam, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 9, 2008
Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopesCarmen Garnacho, Steven M Albelda, Vladimir R Muzykantov, et al.
Blood|December 7, 2002
PECAM-1-dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localizationChristopher D O'Brien, Poay Lim, Jing Sun, et al.
International Journal of Molecular Sciences|March 4, 2016
Asbestos Induces Oxidative Stress and Activation of Nrf2 Signaling in Murine Macrophages: Chemopreventive Role of the Synthetic Lignan Secoisolariciresinol Diglucoside (LGM2605)Ralph A Pietrofesa, Anastasia Velalopoulou, Steven M Albelda, et al.
Biochemical and Biophysical Research Communications|July 14, 2004
Role of lateral cell-cell border location and extracellular/transmembrane domains in PECAM/CD31 mechanosensationDavid A Kaufman, Steven M Albelda, Jing Sun, et al.
Cancers|September 2, 2017
Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)Astero Klampatsa, Andrew R Haas, Edmund K Moon, et al.
Frontiers in Cell and Developmental Biology|November 2, 2016
Diacylglycerol Kinases (DGKs): Novel Targets for Improving T Cell Activity in CancerMatthew J Riese, Edmund K Moon, Bryon D Johnson, et al.
Cancer Biology & Therapy|June 22, 2007
Gemcitabine has significant immunomodulatory activity in murine tumor models independent of its cytotoxic effectsEiji Suzuki, Jing Sun, Veena Kapoor, et al.
Pageof 20